Vaxil Bio: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (VXL)
Vaxil Bio is now ranked among the top 10 undervalued stocks in the Healthcare sector on the TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company. Valuation methodology provided by Stockcalc (see below). The healthcare sector contains companies in biotechnology, pharmaceuticals, hospitals, home and long-term care as well as related medical equipment manufacturers and suppliers.
All data provided as-at market close November 27, 2022. The list is sorted by stocks with the greatest percentage difference between valuation and price. Vaxil Bio Vaxil Bio Ltd is an immuno-oncology biotechnology company. The company is focused on developing novel immunotherapies including neoantigen-like peptide products, and antibodies to treat cancer and infectious diseases. Vaxil Bio is listed under VXL on the TSX Venture Exchange.
| Symbol | Name | Close Price | Shares Outstanding | P/E | P/B | Cash per Share | Net Cash per Share |
|---|---|---|---|---|---|---|---|
| VXL-X | Vaxil Bio | 0.01 | 0 | 0 | 0 | 0 | 0 |
| MNOW-X | Mednow | 0.27 | 0 | 0 | 0 | 0 | 0 |
| JUMP-X | Leveljump Healthcare | 0.07 | 0 | 0 | 0 | 0 | 0 |
| IBO-X | Universal Ibogaine | 0.03 | 0 | 0 | 0 | 0 | 0 |
| NLTA-X | Enlighta | 0.07 | 0 | 0 | 0 | 0 | 0 |
| KNE-X | Kane Biotech | 0.08 | 0 | 0 | 0 | 0 | 0 |
| NLH-X | Nova Leap Health | 0.27 | 0 | 0 | 0 | 0 | 0 |
| ACST-X | Acasti Pharma | 0.56 | 0 | 0 | 0 | 0 | 0 |
| THNK-X | Think Research | 0.32 | 0 | 0 | 0 | 0 | 0 |
| ROMJ-X | Rubicon Organics | 0.64 | 0 | 0 | 0 | 0 | 0 |
More about Vaxil Bio
Stocks in this category are held primarily for capital appreciation.
Artificial intelligence at Report on Business
Artificial Intelligence at Report on Business Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
